A New Overgrowth Syndrome is due to Mutations inRNF125

Authors:
Publisher website
Google Scholar
Abstract
Overgrowth syndromes (OGS) are a group of disorders in which all parameters of growth and physical development are above the mean for age and sex. We evaluated a series of 270 families from the Spanish Overgrowth Syndrome Registry with no known OGS. We identified one de novo deletion and three missense mutations in RNF125 in six patients from four families with overgrowth, macrocephaly, intellectual disability, mild hydrocephaly, hypoglycemia, and inflammatory diseases resembling Sjögren syndrome. RNF125 encodes an E3 ubiquitin ligase and is a novel gene of OGS. Our studies of the RNF125 pathway point to upregulation of RIG‐I‐IPS1‐MDA5 and/or disruption of the PI3K‐AKT and interferon signaling pathways as the putative final effectors.
Funding Information
  • Fondo de Investigación Sanitaria (ISCIII [FIS 11/2491])
  • ENDOSCREEN (S2010/BMD-2396)
  • Marató-TV3
  • EUCID-COST Project (BM1208)
  • Dravet Syndrome Foundation
  • BBK-KutxaBank
  • Spanish Sotos Syndrome Association

This publication has 20 references indexed in Scilit: